罗苏伐他汀可减少血栓形成  

Rosuvastatin Reduced Blood Clot Risk

作　　者：吴河水 

出　　处：《中国医刊》2009年第10期79-80,共2页Chinese Journal of Medicine

摘　　要：一项关于降脂药罗苏伐他汀的大规模试验表明，健康成年人使用罗苏伐他汀后可降低血栓形成（静脉血栓栓塞）的风险达43％。这项结果来自JUPITER试验的一个亚群分析，在线发表于3月2813的《柳叶刀》杂志，并在美国心脏病学会第58届科学年会上宣读。A large trial of the cholesterol lowering drug rosuvastatin showed that givingI it to healthy adults reduced their risk of blood clots （venous thromboembolism） by 43 per cent. This was the result of a subgroup analysis in the JUPITER trial2, and was published online on 28 March in The Lancet and presented at the American College of Cardiology＇ s 58th Annual Scientific Sessions.

关 键 词：罗苏伐他汀 血栓形成 美国心脏病学会 大规模试验 静脉血栓栓塞 健康成年人 《柳叶刀》 降脂药 

分 类 号：R972.6[医药卫生—药品] R364.15[医药卫生—药学]